Determination of colistin in human plasma, urine and other biological samples using LC-MS/MS

被引:56
作者
Ma, Zheng [1 ]
Wang, Jiping [1 ]
Gerber, Jacobus P. [1 ]
Milne, Robert W. [1 ]
机构
[1] Univ S Australia, Sansom Inst, Sch Pharm & Med Sci, Adelaide, SA 5000, Australia
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 862卷 / 1-2期
关键词
colistin; LC-MS/MS; SPE; plasma; urine;
D O I
10.1016/j.jchromb.2007.12.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A liquid chromatography-tandem mass spectrometric (LC-MS/MS) method was developed to quantify colistin in human plasma and urine, and perfusate and urine from the isolated perfused rat kidney (IPK). Solid phase extraction (SPE) preceded chromatography on a Synergi Fusion-RP column with a mobile phase of acetonitrile, water and acetic acid (80/19/1) at 0.2 mL/min. Ions were generated using electrospray ionization and detected in the positive-ion mode. Multiple reaction monitoring was performed using precursor-product ion combinations. Calibration curves were linear from 0.028 mu g/mL (human plasma, IPK perfusate and urine)/0.056 mu g/mL (human urine) to 1.78 mu g/mL (all four media) for colistin A sulfate; corresponding values for colistin B sulfate were 0.016/0.032 to 1.01 mu g/mL. Accuracy and precision were within 10%. The LLOQ for colistin A sulfate was 0.028 mu g/mL in human plasma, IPK perfusate and urine and 0.056 mu g/mL in human urine; corresponding values for colistin B sulfate were 0.016 and 0.032 mu g/mL. The low sample volume, short analysis time and low LLOQ are ideal for pre-clinical and human pharmacokinetic studies of colistin. Crown Copyright (c) 2007 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 26 条
[11]  
KOCH-WESER J, 1970, Annals of Internal Medicine, V72, P857
[12]  
KRISTENSEN HK, 1993, J CHROMATOGR, V628, P309
[13]   High-performance liquid chromatographic method for the determination of colistin in serum [J].
Le Brun, PPH ;
de Graaf, AI ;
Vinks, AATMM .
THERAPEUTIC DRUG MONITORING, 2000, 22 (05) :589-593
[14]   RESIDUE DETERMINATION OF 2 CO-ADMINISTERED ANTIBACTERIAL AGENTS CEPHALEXIN AND COLISTIN IN CALF TISSUES USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND MICROBIOLOGICAL METHODS [J].
LEROY, P ;
DECOLIN, D ;
NICOLAS, S ;
ARCHIMBAULT, P ;
NICOLAS, A .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1989, 7 (12) :1837-1846
[15]   Evaluation of colistin as an agent against multi-resistant in Gram-negative bacteria [J].
Li, J ;
Nation, RL ;
Milne, RW ;
Turnidge, JD ;
Coulthard, K .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2005, 25 (01) :11-25
[16]   Stability of colistin and colistin methanesulfonate in aqueous media and plasma as determined by high-performance liquid chromatography [J].
Li, J ;
Milne, RW ;
Nation, RL ;
Turnidge, JD ;
Coulthard, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (04) :1364-1370
[17]   A simple method for the assay of colistin in human plasma, using pre-column derivatization with 9-fluorenylmethyl chloroformate in solid-phase extraction cartridges and reversed-phase high-performance liquid chromatography [J].
Li, J ;
Milne, RW ;
Nation, RL ;
Turnidge, JD ;
Coulthard, K ;
Johnson, DW .
JOURNAL OF CHROMATOGRAPHY B, 2001, 761 (02) :167-175
[18]   Development and validation of a liquid chromatography method for analysis of colistin sulphate [J].
Orwa, JA ;
Van Gerven, A ;
Roets, E ;
Hoogmartens, J .
CHROMATOGRAPHIA, 2000, 51 (7-8) :433-436
[19]   The pharmacokinetics of colistin in patients with cystic fibrosis [J].
Reed, MD ;
Stern, RC ;
O'Riordan, MA ;
Blumer, JL .
JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 41 (06) :645-654
[20]   Bioanalytical Method Validation—A Revisit with a Decade of Progress [J].
Vinod P. Shah ;
Kamal K. Midha ;
John W. A. Findlay ;
Howard M. Hill ;
James D. Hulse ;
Iain J. McGilveray ;
Gordon McKay ;
Krys J. Miller ;
Rabindra N. Patnaik ;
Mark L. Powell ;
Alfred Tonelli ;
C. T. Viswanathan ;
Avraham Yacobi .
Pharmaceutical Research, 2000, 17 (12) :1551-1557